MCAZ Implements Stricter Border Screening for Imported Medicines

The Medicines Control Authority of Zimbabwe (MCAZ) has initiated a new protocol to screen all imported medicines at the country's ports of entry. This regulatory tightening aims to curb the influx of substandard or illicit pharmaceuticals that have bypassed traditional oversight mechanisms. The move follows growing concerns regarding the safety and efficacy of drugs entering the domestic market. By centralizing control at the border, the MCAZ seeks to enforce stricter compliance standards on importers and distributors. The policy shift represents a significant escalation in the regulator's efforts to secure the national supply chain against unregulated medical products.